FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

2475211000001104: Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25386901000001118 Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58844601000001113 Parlodel 2.5mg tablets (Meda Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Is a Bromocriptine 2.5mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Is pack of Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) false Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has active ingredient Bromocriptine mesilate false Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has active ingredient Bromocriptine false Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has AMP Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Bromocriptine true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has specific active ingredient Bromocriptine mesilate true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has basis of strength substance Bromocriptine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start